We thus hypothesized that β2AR contributes to an aggressive phenotype in HPV( + ) HNSCC, in part through modulation of mitochondrial activity, and may be a worthwhile therapeutic target in this setting. This evidence concerns the gene ADRB2 and head and neck squamous cell carcinoma.